vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and RESOURCES CONNECTION, INC. (RGP). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $117.7M, roughly 1.0× RESOURCES CONNECTION, INC.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -10.8%, a 15.0% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (-1.4% vs -19.2%). RESOURCES CONNECTION, INC. produced more free cash flow last quarter ($15.6M vs $517.0K). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -11.8%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

RGP, formerly known as Resources Global Professionals, is the operating arm of Resources Connection, Inc.. The company provides consulting services in the areas of finance & accounting, information management, governance, risk & compliance (GRC), human capital, legal & regulatory, corporate advisory & restructuring, strategic communications, and supply chain management. As of fiscal year ending May 28, 2016, the company employed 3,283 professionals in 68 offices in 20 countries around the wor...

CLB vs RGP — Head-to-Head

Bigger by revenue
CLB
CLB
1.0× larger
CLB
$121.8M
$117.7M
RGP
Growing faster (revenue YoY)
CLB
CLB
+17.7% gap
CLB
-1.4%
-19.2%
RGP
Higher net margin
CLB
CLB
15.0% more per $
CLB
4.2%
-10.8%
RGP
More free cash flow
RGP
RGP
$15.1M more FCF
RGP
$15.6M
$517.0K
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-11.8%
RGP

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CLB
CLB
RGP
RGP
Revenue
$121.8M
$117.7M
Net Profit
$5.1M
$-12.7M
Gross Margin
37.1%
Operating Margin
1.5%
-10.3%
Net Margin
4.2%
-10.8%
Revenue YoY
-1.4%
-19.2%
Net Profit YoY
81.6%
EPS (diluted)
$0.11
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
RGP
RGP
Q1 26
$121.8M
Q4 25
$138.3M
$117.7M
Q3 25
$134.5M
$120.2M
Q2 25
$130.2M
$139.3M
Q1 25
$123.6M
$129.4M
Q4 24
$129.2M
$145.6M
Q3 24
$134.4M
$136.9M
Q2 24
$130.6M
$148.2M
Net Profit
CLB
CLB
RGP
RGP
Q1 26
$5.1M
Q4 25
$4.9M
$-12.7M
Q3 25
$14.2M
$-2.4M
Q2 25
$10.6M
$-73.3M
Q1 25
$-154.0K
$-44.1M
Q4 24
$7.4M
$-68.7M
Q3 24
$11.7M
$-5.7M
Q2 24
$9.0M
$10.5M
Gross Margin
CLB
CLB
RGP
RGP
Q1 26
Q4 25
20.8%
37.1%
Q3 25
22.0%
39.5%
Q2 25
20.3%
40.2%
Q1 25
19.5%
35.1%
Q4 24
17.8%
38.5%
Q3 24
20.5%
36.5%
Q2 24
21.2%
40.2%
Operating Margin
CLB
CLB
RGP
RGP
Q1 26
1.5%
Q4 25
11.5%
-10.3%
Q3 25
15.6%
-1.7%
Q2 25
11.7%
-47.0%
Q1 25
3.6%
-38.4%
Q4 24
11.0%
-52.7%
Q3 24
14.7%
-3.5%
Q2 24
12.3%
7.6%
Net Margin
CLB
CLB
RGP
RGP
Q1 26
4.2%
Q4 25
3.6%
-10.8%
Q3 25
10.6%
-2.0%
Q2 25
8.2%
-52.6%
Q1 25
-0.1%
-34.0%
Q4 24
5.7%
-47.2%
Q3 24
8.7%
-4.2%
Q2 24
6.9%
7.1%
EPS (diluted)
CLB
CLB
RGP
RGP
Q1 26
$0.11
Q4 25
$0.11
$-0.38
Q3 25
$0.30
$-0.07
Q2 25
$0.22
$-2.21
Q1 25
$0.00
$-1.34
Q4 24
$0.15
$-2.08
Q3 24
$0.25
$-0.17
Q2 24
$0.19
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
RGP
RGP
Cash + ST InvestmentsLiquidity on hand
$22.8M
$89.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$194.6M
Total Assets
$587.7M
$289.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
RGP
RGP
Q1 26
$22.8M
Q4 25
$22.7M
$89.8M
Q3 25
$25.6M
$77.5M
Q2 25
$31.2M
$86.1M
Q1 25
$22.1M
$72.5M
Q4 24
$19.2M
$78.2M
Q3 24
$21.5M
$89.6M
Q2 24
$17.7M
$108.9M
Total Debt
CLB
CLB
RGP
RGP
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
RGP
RGP
Q1 26
$275.1M
Q4 25
$266.0M
$194.6M
Q3 25
$271.3M
$206.4M
Q2 25
$261.3M
$207.1M
Q1 25
$253.4M
$277.8M
Q4 24
$246.6M
$325.7M
Q3 24
$250.7M
$407.2M
Q2 24
$240.3M
$418.8M
Total Assets
CLB
CLB
RGP
RGP
Q1 26
$587.7M
Q4 25
$584.0M
$289.3M
Q3 25
$591.4M
$287.2M
Q2 25
$602.1M
$304.7M
Q1 25
$591.5M
$375.6M
Q4 24
$585.1M
$424.9M
Q3 24
$600.5M
$512.9M
Q2 24
$597.8M
$510.9M
Debt / Equity
CLB
CLB
RGP
RGP
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
RGP
RGP
Operating Cash FlowLast quarter
$4.0M
$15.9M
Free Cash FlowOCF − Capex
$517.0K
$15.6M
FCF MarginFCF / Revenue
0.4%
13.2%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$24.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
RGP
RGP
Q1 26
$4.0M
Q4 25
$7.9M
$15.9M
Q3 25
$8.5M
$-7.8M
Q2 25
$13.9M
$16.8M
Q1 25
$6.7M
$659.0K
Q4 24
$20.6M
$1.8M
Q3 24
$13.1M
$-309.0K
Q2 24
$17.1M
$3.2M
Free Cash Flow
CLB
CLB
RGP
RGP
Q1 26
$517.0K
Q4 25
$5.0M
$15.6M
Q3 25
$6.5M
$-8.0M
Q2 25
$10.4M
$16.5M
Q1 25
$3.9M
$238.0K
Q4 24
$17.4M
$61.0K
Q3 24
$10.4M
$-575.0K
Q2 24
$14.3M
$3.0M
FCF Margin
CLB
CLB
RGP
RGP
Q1 26
0.4%
Q4 25
3.6%
13.2%
Q3 25
4.8%
-6.6%
Q2 25
8.0%
11.8%
Q1 25
3.1%
0.2%
Q4 24
13.4%
0.0%
Q3 24
7.7%
-0.4%
Q2 24
10.9%
2.1%
Capex Intensity
CLB
CLB
RGP
RGP
Q1 26
Q4 25
2.1%
0.3%
Q3 25
1.5%
0.1%
Q2 25
2.7%
0.2%
Q1 25
2.3%
0.3%
Q4 24
2.5%
1.2%
Q3 24
2.0%
0.2%
Q2 24
2.2%
0.1%
Cash Conversion
CLB
CLB
RGP
RGP
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×
0.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

RGP
RGP

US$93.7M80%
Non Us$24.0M20%

Related Comparisons